AliveCor Ltd is pioneering the creation of CE marked, FDA-cleared machine learning techniques to enable proactive heart care and is recognised around the world for transforming cardiac care. Inaugural member of NHS England’s Innovation Accelerator; and now the centrally funded  KardiaMobile™ is being made available to Primary Care for AF case finding via the NHS Innovation & Technology Tariff. It is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. KardiaMobile, and KardiaBand™, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. KardiaBand is the first FDA-cleared medical device accessory for Apple Watch. AliveCor was recognized by Fast Company as one of 2017’s most innovative companies in health (#3). AliveCor Ltd is a subsidiary of AliveCor Inc., a privately-held company headquartered in Mountain View, Calif. For more information, please visit:
  • London PCN Event